Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Alcon Inc. | Bullish | Bullish |
Stockmoo Score
|
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Large Growth |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 110.00 (Oppenheimer, 22.66%) | Buy |
| 110.00 (Baird, 22.66%) | Buy | |
| Median | 106.00 (18.20%) | |
| Low | 85.00 (Morgan Stanley, -5.22%) | Hold |
| Average | 103.50 (15.41%) | |
| Total | 5 Buy, 1 Hold | |
| Avg. Price @ Call | 95.34 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 12 Sep 2024 | 104.00 (15.97%) | Buy | 100.76 |
| 22 Aug 2024 | 98.00 (9.28%) | Buy | 95.33 | |
| Baird | 22 Aug 2024 | 110.00 (22.66%) | Buy | 95.33 |
| Needham | 22 Aug 2024 | 107.00 (19.31%) | Buy | 95.33 |
| 21 Aug 2024 | 101.00 (12.62%) | Buy | 94.62 | |
| Oppenheimer | 22 Aug 2024 | 110.00 (22.66%) | Buy | 95.33 |
| Wells Fargo | 22 Aug 2024 | 105.00 (17.08%) | Buy | 95.33 |
| Morgan Stanley | 15 Jul 2024 | 85.00 (-5.22%) | Hold | 89.96 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 20 Aug 2024 | Announcement | Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses |
| 24 Jun 2024 | Announcement | Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance |
| TTM Dividend Yield | 0.30% |
| 3Y Average Dividend Yield | 0.24% |
| Expected Next Dividend Payment | May 2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 14 May 2024 | 08 Apr 2024 | 16 May 2024 | 0.2644 Cash |
| 10 May 2023 | 30 Mar 2023 | 12 May 2023 | 0.2356 Cash |
| 29 Apr 2022 | 24 Mar 2022 | 05 May 2022 | 0.2083 Cash |
| 04 May 2021 | 24 Mar 2021 | 06 May 2021 | 0.0909 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 0.264 | 1 | 0.30 |
| 2023 | 0.236 | 1 | 0.30 |
| 2022 | 0.208 | 1 | 0.30 |
| 2021 | 0.091 | 1 | 0.10 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |